Patient info

A16AB Enzymes for alimentary tract and metabolism

ATC group of level 4 – chemical subgroup · in plain English: medicines for rare metabolic diseases

This site has the patient leaflet or the SPC of 21 medicines in this group and its subgroups.

Place in the ATC classification

  1. A Alimentary tract and metabolism drugs 1,624 medicines
    1. A16 Other alimentary tract and metabolism products 95 medicines
      1. A16A Other alimentary tract and metabolism products 95 medicines
        1. A16AB Enzymes for alimentary tract and metabolism 21 medicines
          1. A16AB02 imiglucerase 1 medicine
          2. A16AB03 agalsidase alfa 1 medicine
          3. A16AB04 agalsidase beta 2 medicines
          4. A16AB05 laronidase 1 medicine
          5. A16AB07 alglucosidase alfa 2 medicines
          6. A16AB08 galsulfase 1 medicine
          7. A16AB09 idursulfase 1 medicine
          8. A16AB10 velaglucerase alfa 2 medicines
          9. A16AB12 elosulfase alfa 1 medicine
          10. A16AB13 asfotase alfa 2 medicines
          11. A16AB14 sebelipase alfa 1 medicine
          12. A16AB15 velmanase alfa 1 medicine
          13. A16AB17 cerliponase alfa 1 medicine
          14. A16AB18 vestronidase alfa 2 medicines
          15. A16AB19 pegvaliase 1 medicine

4 more subgroups have no medicine with a leaflet on this site.

Active substances in the group

Medicines in the group and its subgroups

MedicineLegal category
Aldurazyme 100 U/ml concentrate for solution for infusion SPC (A16AB05 laronidase) Prescription only (POM)
Brineura SPC Prescription only (POM)
Brineura 150 mg solution for infusion SPC (A16AB17 cerliponase alfa) Prescription only (POM)
Cerezyme 400 units powder for concentrate for solution for infusion SPC (A16AB02 imiglucerase) Prescription only (POM)
Elaprase 2 mg / ml concentrate for solution for infusion SPC (A16AB09 idursulfase) Prescription only (POM)
Fabrazyme 35 mg powder for concentrate for solution for infusion SPC (A16AB04 agalsidase beta) Prescription only (POM)
Fabrazyme 5 mg powder for concentrate for solution for infusion SPC (A16AB04 agalsidase beta) Prescription only (POM)
Kanuma 2 mg / ml concentrate for solution for infusion SPC (A16AB14 sebelipase alfa) Prescription only (POM)
Lamzede 10 mg powder for solution for infusion SPC (A16AB15 velmanase alfa) Prescription only (POM)
Mepsevii SPC (A16AB18 vestronidase alfa) Prescription only (POM)
Mepsevii 2 mg / ml concentrate for solution for infusion SPC (A16AB18 vestronidase alfa) Prescription only (POM)
Myozyme SPC (A16AB07 alglucosidase alfa) Prescription only (POM)
Myozyme 50 mg powder for concentrate for solution for infusion SPC (A16AB07 alglucosidase alfa) Prescription only (POM)
Naglazyme 1 mg/ml concentrate for solution for infusion SPC Prescription only (POM)
Palynziq SPC (A16AB19 pegvaliase) –
Replagal 1 mg / ml concentrate for solution for infusion SPC no longer supplied (A16AB03 agalsidase alfa) –
Strensiq 100 mg / ml solution for injection (A16AB13 asfotase alfa) Prescription only (POM)
Strensiq 40 mg / ml solution for injection SPC –
Vimizim 1 mg / ml concentrate for solution for infusion SPC (A16AB12 elosulfase alfa) Prescription only (POM)
Vpriv SPC (A16AB10 velaglucerase alfa) Prescription only (POM)
Vpriv 400 units powder for solution for infusion SPC (A16AB10 velaglucerase alfa) Prescription only (POM)

Other groups of the same level

Other names of the ATC group

Sources

  • Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
  • Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
  • World Health Organization (WHO): ATC/DDD classification, group A16AB

Contains public sector information licensed under the Open Government Licence v3.0.

Ask your doctor or pharmacist which medicine is right for you.